Abstract

Research Article

Effects of Zinc Supplementation on Oxidative Stress in Patients Undergoing Maintenance Hemodialysis

Marwa Hajji*, Mehdi Mrad, Ines Bini, Afef Bahlous, Rania Khedher, Karim Zouaghi, Moncef Feki and Hayet Fellah

Published: 20 October, 2023 | Volume 7 - Issue 3 | Pages: 085-089

Introduction: The aim of this study was to examine the effects of Zn supplementation on oxidative stress by evaluating changes in serum Copper (Cu) to Zinc (Zn) ratio, homocysteine (hCys), Glutathione (GSH), Total Bilirubin (TB) and Catalase (CAT) activity in hemodialysis patients.
Methods: Seventy-seven HD patients were enrolled in a multicenter simple-blind randomized clinical trial. Only 37 HD patients completed the study. They were randomly divided into two groups and supplemented with zinc sulfate (n = 17) or placebo (n = 20) for two months. Serum Zn and Cu were measured by atomic absorption spectrophotometry. Serum hCys was measured by immunology method, serum GSH and CAT activity were assessed by spectrophotometry method and TB was measured by colorimetric method. Determinations were performed before and after supplementation.
Findings: After zinc supplementation, serum Zn, serum GSH, and Serum Total Bilirubin (STB) significantly increased. Serum Cu to Zn ratio, serum hCys, and CAT activity significantly decreased in the Zn Zn-supplemented group.
Conclusion: Zinc supplementation increased serum antioxidant factors such as Zn, GSH, and bilirubin and decreased serum oxidative factors such as copper to zinc ratio, hCys, and decreased CAT activity. The study results suggest that zinc supplementation may be a useful tool for the improvement of oxidative stress in HD patients.

Read Full Article HTML DOI: 10.29328/journal.jcn.1001116 Cite this Article Read Full Article PDF

Keywords:

Hemodialysis; Zn supplement; Copper to zinc ratio; Catalase activity; Homocysteine; Glutathione; Total bilirubin

References

  1. Wright J, Hutchison A. Cardiovascular disease in patients with chronic kidney disease. Vasc Health Risk Manag. 2009;5:713-22. doi: 10.2147/vhrm.s6206. Epub 2009 Sep 7. PMID: 19756163; PMCID: PMC2742701.
  2. Guo CH, Chen PC, Yeh MS, Hsiung DY, Wang CL. Cu/Zn ratios are associated with nutritional status, oxidative stress, inflammation, and immune abnormalities in patients on peritoneal dialysis. Clin Biochem. 2011 Mar;44(4):275-80. doi: 10.1016/j.clinbiochem.2010.12.017. Epub 2011 Jan 9. PMID: 21223959.
  3. Rysz J, Franczyk B, Ławiński J, Gluba-Brzózka A. Oxidative Stress in ESRD Patients on Dialysis and the Risk of Cardiovascular Diseases. Antioxidants (Basel). 2020 Nov 3;9(11):1079. doi: 10.3390/antiox9111079. PMID: 33153174; PMCID: PMC7693989.
  4. Takic M, Zekovic M, Terzic B, Stojsavljevic A, Mijuskovic M, Radjen S, Ristic-Medic D. Zinc Deficiency, Plasma Fatty Acid Profile and Desaturase Activities in Hemodialysis Patients: Is Supplementation Necessary? Front Nutr. 2021 Sep 23;8:700450. doi: 10.3389/fnut.2021.700450. PMID: 34631763; PMCID: PMC8496936.
  5. Sun JY, Jing MY, Wang JF, Zi NT, Fu LJ, Lu MQ, Pan L. Effect of zinc on biochemical parameters and changes in related gene expression assessed by cDNA microarrays in pituitary of growing rats. Nutrition. 2006 Feb;22(2):187-96. doi: 10.1016/j.nut.2005.07.007. Epub 2006 Jan 18. PMID: 16413754.
  6. Prasad AS. Clinical, immunological, anti-inflammatory and antioxidant roles of zinc. Exp Gerontol. 2008 May;43(5):370-7. doi: 10.1016/j.exger.2007.10.013. Epub 2007 Nov 1. PMID: 18054190.
  7. Jern NA, VanBeber AD, Gorman MA, Weber CG, Liepa GU, Cochran CC. The effects of zinc supplementation on serum zinc concentration and protein catabolic rate in hemodialysis patients. J Ren Nutr. 2000 Jul;10(3):148-53. doi: 10.1053/jren.2000.7413. PMID: 10921536.
  8. Guo CH, Wang CL. Effects of zinc supplementation on plasma copper/zinc ratios, oxidative stress, and immunological status in hemodialysis patients. Int J Med Sci. 2013;10(1):79-89. doi: 10.7150/ijms.5291. Epub 2012 Dec 22. PMID: 23289009; PMCID: PMC3534881.
  9. Elgenidy A, Amin MA, Awad AK, Husain-Syed F, Aly MG. Serum Zinc Levels in Chronic Kidney Disease Patients, Hemodialysis Patients, and Healthy Controls: Systematic Review and Meta-Analysis. J Ren Nutr. 2023 Jan;33(1):103-115. doi: 10.1053/j.jrn.2022.04.004. Epub 2022 Apr 25. PMID: 35472507.
  10. Rashidi AA, Salehi M, Piroozmand A, Sagheb MM. Effects of zinc supplementation on serum zinc and C-reactive protein concentrations in hemodialysis patients. J Ren Nutr. 2009 Nov;19(6):475-8. doi: 10.1053/j.jrn.2009.04.005. Epub 2009 Jun 21. PMID: 19541504.
  11. Dashti-Khavidaki S, Khalili H, Vahedi SM, Lessan-Pezeshki M. Serum zinc concentrations in patients on maintenance hemodialysis and its relationship with anemia, parathyroid hormone concentrations and pruritus severity. Saudi J Kidney Dis Transpl. 2010 Jul;21(4):641-5. PMID: 20587866.
  12. Shiota J, Tagawa H, Izumi N, Higashikawa S, Kasahara H. Effect of zinc supplementation on bone formation in hemodialysis patients with normal or low turnover bone. Ren Fail. 2015 Feb;37(1):57-60. doi: 10.3109/0886022X.2014.959412. Epub 2014 Sep 10. PMID: 25207792.
  13. Bozalioğlu S, Ozkan Y, Turan M, Simşek B. Prevalence of zinc deficiency and immune response in short-term hemodialysis. J Trace Elem Med Biol. 2005;18(3):243-9. doi: 10.1016/j.jtemb.2005.01.003. PMID: 15966573.
  14. Kiziltas H, Ekin S, Erkoc R. Trace element status of chronic renal patients undergoing hemodialysis. Biol Trace Elem Res. 2008 Aug;124(2):103-9. doi: 10.1007/s12011-008-8135-6. Epub 2008 Apr 15. PMID: 18414814.
  15. Liuzzi JP, Cousins RJ. Mammalian zinc transporters. Annu Rev Nutr. 2004;24:151-72. doi: 10.1146/annurev.nutr.24.012003.132402. PMID: 15189117.
  16. Ghoreshi Z, Ahaley SK, Rasooli I. Effect of haemodialysis on trace elements in patients with acute and chronic renal failure. M J I R I. 2001; 14(4):329-331.
  17. Maggini S, Wintergerst ES, Beveridge S, Hornig DH. Selected vitamins and trace elements support immune function by strengthening epithelial barriers and cellular and humoral immune responses. Br J Nutr. 2007 Oct;98 Suppl 1:S29-35. doi: 10.1017/S0007114507832971. PMID: 17922955.
  18. Sudha R, Ponsuganthi K, Jones R. Serum zinc and copper levels in maintenance haemodialysis patients and its relationship with depression and anxiety. G J Med P H. 2015 ; 4.
  19. Karahan SC, Değer O, Orem A, Uçar F, Erem C, Alver A, Onder E. The effects of impaired trace element status on polymorphonuclear leukocyte activation in the development of vascular complications in type 2 diabetes mellitus. Clin Chem Lab Med. 2001 Feb;39(2):109-15. doi: 10.1515/CCLM.2001.019. PMID: 11341743.
  20. Malavolta M, Giacconi R, Piacenza F, Santarelli L, Cipriano C, Costarelli L, Tesei S, Pierpaoli S, Basso A, Galeazzi R, Lattanzio F, Mocchegiani E. Plasma copper/zinc ratio: an inflammatory/nutritional biomarker as predictor of all-cause mortality in elderly population. Biogerontology. 2010 Jun;11(3):309-19. doi: 10.1007/s10522-009-9251-1. Epub 2009 Oct 10. PMID: 19821050.
  21. Bostom AG, Shemin D, Verhoef P, Nadeau MR, Jacques PF, Selhub J, Dworkin L, Rosenberg IH. Elevated fasting total plasma homocysteine levels and cardiovascular disease outcomes in maintenance dialysis patients. A prospective study. Arterioscler Thromb Vasc Biol. 1997 Nov;17(11):2554-8. doi: 10.1161/01.atv.17.11.2554. PMID: 9409227.
  22. Moustapha A, Naso A, Nahlawi M, Gupta A, Arheart KL, Jacobsen DW, Robinson K, Dennis VW. Prospective study of hyperhomocysteinemia as an adverse cardiovascular risk factor in end-stage renal disease. Circulation. 1998 Jan 20;97(2):138-41. doi: 10.1161/01.cir.97.2.138. Erratum in: Circulation 1998 Feb 24;97(7):711. PMID: 9445164.
  23. Williams RB, Mills CF, Davidson RJ. Relationships between zinc deficiency and folic acid status of the rat. Proc Nutr Soc. 1973 May;32(1):2A-3A. PMID: 4760784.
  24. Tamura T, Shane B, Baer MT, King JC, Margen S, Stokstad EL. Absorption of mono- and polyglutamyl folates in zinc-depleted man. Am J Clin Nutr. 1978 Nov;31(11):1984-7. doi: 10.1093/ajcn/31.11.1984. PMID: 717270.
  25. Samman S, Foster M. Zinc and cardio-metabolic health in type 2 diabetes mellitus. Vitam Trace Elem. 2013; 2:116.
  26. Mariani E, Mangialasche F, Feliziani FT, Cecchetti R, Malavolta M, Bastiani P, Baglioni M, Dedoussis G, Fulop T, Herbein G, Jajte J, Monti D, Rink L, Mocchegiani E, Mecocci P. Effects of zinc supplementation on antioxidant enzyme activities in healthy old subjects. Exp Gerontol. 2008 May;43(5):445-51. doi: 10.1016/j.exger.2007.10.012. Epub 2007 Nov 1. PMID: 18078731.
  27. Boon AC, Bulmer AC, Coombes JS, Fassett RG. Circulating bilirubin and defense against kidney disease and cardiovascular mortality: mechanisms contributing to protection in clinical investigations. Am J Physiol Renal Physiol. 2014 Jul 15;307(2):F123-36. doi: 10.1152/ajprenal.00039.2014. Epub 2014 Apr 23. PMID: 24761005.
  28. Wagner KH, Wallner M, Mölzer C, Gazzin S, Bulmer AC, Tiribelli C, Vitek L. Looking to the horizon: the role of bilirubin in the development and prevention of age-related chronic diseases. Clin Sci (Lond). 2015 Jul;129(1):1-25. doi: 10.1042/CS20140566. PMID: 25881719.
  29. Kapitulnik J. Bilirubin: an endogenous product of heme degradation with both cytotoxic and cytoprotective properties. Mol Pharmacol. 2004 Oct;66(4):773-9. doi: 10.1124/mol.104.002832. Epub 2004 Jul 21. PMID: 15269289.
  30. Vítek L. The role of bilirubin in diabetes, metabolic syndrome, and cardiovascular diseases. Front Pharmacol. 2012 Apr 3;3:55. doi: 10.3389/fphar.2012.00055. PMID: 22493581; PMCID: PMC3318228.
  31. Mayer M. Association of serum bilirubin concentration with risk of coronary artery disease. Clin Chem. 2000 Nov;46(11):1723-7. PMID: 11067805.
  32. Ratliff BB, Abdulmahdi W, Pawar R, Wolin MS. Oxidant Mechanisms in Renal Injury and Disease. Antioxid Redox Signal. 2016 Jul 20;25(3):119-46. doi: 10.1089/ars.2016.6665. Epub 2016 Apr 26. PMID: 26906267; PMCID: PMC4948213.
  33. Maines MD, Polevoda BV, Huang TJ, McCoubrey WK Jr. Human biliverdin IXalpha reductase is a zinc-metalloprotein. Characterization of purified and Escherichia coli expressed enzymes. Eur J Biochem. 1996 Jan 15;235(1-2):372-81. doi: 10.1111/j.1432-1033.1996.00372.x. PMID: 8631357.

Figures:

Figure 1

Figure 1

Figure 1

Figure 2

Similar Articles

Recently Viewed

  • Osseous Choristoma with in a Dermolipoma: 17 Years Old Girl Case Report
    Julian Bermúdez Pío-Rendón, Francisco Javier Vicente Andreu, David Cerdán Palacios and Vanessa Díaz Mesa* Julian Bermúdez Pío-Rendón, Francisco Javier Vicente Andreu, David Cerdán Palacios, Vanessa Díaz Mesa*. Osseous Choristoma with in a Dermolipoma: 17 Years Old Girl Case Report. Int J Clin Exp Ophthalmol. 2023: doi: 10.29328/journal.ijceo.1001053; 7: 008-010
  • Clinically Observable Ocular Manifestations of Axonal Transport
    Don Minckler*, Ken Y Lin and Michael C Yang Don Minckler*, Ken Y Lin, Michael C Yang. Clinically Observable Ocular Manifestations of Axonal Transport. Int J Clin Exp Ophthalmol. 2023: doi: 10.29328/journal.ijceo.1001052; 7: 006-007
  • Exit Site Care in Peritoneal Dialysis: Silver as a Possible Strategy?
    Paribello Giuseppe*, Papa Fortuna, Ganzerli Maria Chiara, Del Prete Chiara, Capuano Ivana, Pacella Daniela, Sannino Giuseppina, Rompianesi Gianluca, Pisani Antonio and Riccio Eleonora Paribello Giuseppe*, Papa Fortuna, Ganzerli Maria Chiara, Del Prete Chiara, Capuano Ivana, Pacella Daniela, Sannino Giuseppina, Rompianesi Gianluca, Pisani Antonio, Riccio Eleonora. Exit Site Care in Peritoneal Dialysis: Silver as a Possible Strategy?. J Clini Nephrol. 2024: doi: 10.29328/journal.jcn.1001121; 8: 017-022
  • Characteristics of Juvenile Sex Offenders in Poland
    Anna Więcek-Durańska* Anna Więcek-Durańska*. Characteristics of Juvenile Sex Offenders in Poland. J Forensic Sci Res. 2023: doi: 10.29328/journal.jfsr.1001053; 7: 072-076
  • Galenic hospital laboratory during COVID-19 emergency: A practical experience in an advanced country
    Luisetto M*, Fiazza C, Ferraiuolo A and Ram Sahu Luisetto M*,Fiazza C,Ferraiuolo A,Ram Sahu. Galenic hospital laboratory during COVID-19 emergency: A practical experience in an advanced country. Int J Clin Virol. 2020: doi: 10.29328/journal.ijcv.1001027; 4: 118-125

Read More

Most Viewed

Read More

Help ?